Department of Traditional Chinese Medicine, Gansu Medical College, Pingliang 744000, China.
Sanitation Test Center, Pingliang Center for Disease Control and Prevention, Pingliang 744000, China.
Molecules. 2023 Jun 27;28(13):5022. doi: 10.3390/molecules28135022.
Dandelion ( genus) is a perennial herb belonging to the Asteraceae family. As a well-known and extensively studied genus, dandelion comprises numerous species. Some species have been widely used in both complementary and alternative medicine to clear heat, detoxify, activate blood circulation, dispel stasis, and discharge urine. Multiple pharmacological studies have highlighted its therapeutic potential, including anti-bacterial, anti-oxidant, anti-cancer, and anti-rheumatic activities. Furthermore, bioactive compounds associated with these effects include sesquiterpenoids, phenolic compounds, essential oils, saccharides, flavonoids, sphingolipids, triterpenoids, sterols, coumarins, etc. Based on recent studies about the genus, the present review critically evaluates the current state of dandelion utilization and summarizes the significant roles of dandelion and its constituents in different diseases. We also focus on the reported phytology, chemical composition, pharmacology, and toxicity of dandelion, along with the main possible action mechanisms behind their therapeutic activities. Meanwhile, the challenges and future directions of the genus are also prospected in this review, thus highlighting its pharmaceutical research and practical clinical applications.
蒲公英(属)是菊科的一种多年生草本植物。作为一个广为人知且被广泛研究的属,蒲公英包含许多物种。一些物种在补充和替代医学中被广泛使用,以清热、解毒、活血、化瘀、利尿。多项药理学研究强调了其治疗潜力,包括抗菌、抗氧化、抗癌和抗风湿活性。此外,与这些作用相关的生物活性化合物包括倍半萜、酚类化合物、精油、糖类、类黄酮、鞘脂类、三萜类、甾醇、香豆素等。基于最近对该属的研究,本综述批判性地评价了蒲公英的利用现状,并总结了蒲公英及其成分在不同疾病中的重要作用。我们还重点介绍了蒲公英的植物学、化学成分、药理学和毒性,以及其治疗活性背后的主要可能作用机制。同时,还展望了该属的挑战和未来方向,突出了其在药物研究和实际临床应用中的潜力。
Biomed Pharmacother. 2024-10
J Ethnopharmacol. 2022-7-15
Nutr Rev. 2012-8-17
Rev Diabet Stud. 2016
World J Gastroenterol. 2025-8-7
Med Pharm Rep. 2025-7
Pharmaceuticals (Basel). 2025-7-1
Curr Issues Mol Biol. 2025-6-11
Pharmaceuticals (Basel). 2025-4-30
Metabolites. 2025-5-3
Evid Based Complement Alternat Med. 2022-5-24
J Ethnopharmacol. 2022-7-15
Phytochem Anal. 2021-11
Evid Based Complement Alternat Med. 2018-1-1
Med Sci (Basel). 2015-6-11